What is the official website of Novartis México ?

The official website of Novartis México is www.novartis.com/mx-es.

What is Novartis México's cybersecurity risk score?

Novartis México has an AI-generated cybersecurity risk score of 759 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Novartis México experienced?

According to Rankiteo, Novartis México currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Novartis México been affected by any supply chain cyber incidents ?

According to Rankiteo, Novartis México has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Novartis México have SOC 2 Type 1 certification ?

According to Rankiteo, Novartis México is not certified under SOC 2 Type 1.

Does Novartis México have SOC 2 Type 2 certification ?

According to Rankiteo, Novartis México does not hold a SOC 2 Type 2 certification.

Does Novartis México comply with GDPR ?

According to Rankiteo, Novartis México is not listed as GDPR compliant.

Does Novartis México have PCI DSS certification ?

According to Rankiteo, Novartis México does not currently maintain PCI DSS compliance.

Does Novartis México comply with HIPAA ?

According to Rankiteo, Novartis México is not compliant with HIPAA regulations.

Does Novartis México have ISO 27001 certification ?

According to Rankiteo,Novartis México is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Novartis México operate in ?

Novartis México operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Novartis México have ?

Novartis México employs approximately 607 people worldwide.

Does Novartis México own any subsidiaries ?

Novartis México presently has no subsidiaries across any sectors.

How many LinkedIn followers does Novartis México have ?

Novartis México's official LinkedIn profile has approximately 96,715 followers.

What is the NAICS classification code for Novartis México ?

Novartis México is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Novartis México have a Crunchbase profile ?

No, Novartis México does not have a profile on Crunchbase.

Does Novartis México have a LinkedIn profile ?

Yes, Novartis México maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/novartismexico.

How many cybersecurity incidents has Novartis México experienced ?

As of August 18, 2026, Rankiteo reports that Novartis México has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Novartis México have ?

Novartis México has an estimated 5,729 peer or competitor companies worldwide.

What types of cybersecurity incidents has Novartis México faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Cyber Attack and Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Novartis México

Boost Score +25 with badge (5 left)

759

/1000

Fair

784

/1000

Fair

Novartis México Vendor Cyber Rating & Cyber Score

novartis.com

Add Your Compliance Badge

Novartis Farmacéutica, S.A. de C.V. es individualmente “Responsable” de recabar sus datos personales, con domicilio en Av. Insurgentes Sur 2475, Tizapán San Ángel, Álvaro Obregón, 01090 Ciudad de México. Los datos personales que usted nos proporcione serán utilizados para cumplimentar la legislación respectiva. Para consultar nuestro Aviso de Privacidad Integral y los mecanismos para ejercer sus derechos, por favor visite www.novartis.com/mx-es Somos una compañía global con base en Suiza en la que buscamos descubrir nuevos caminos para prolongar y mejorar la vida de los pacientes en el mundo. Debes estar al tanto de los anuncios de trabajo falsos. En Novartis estamos consciente de las estafas recientes que hacen mal uso del nombre de

Novartis México A.I CyberSecurity Scoring

Scoring History

Novartis México

Novartis México CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Novartis

Breach

2/2026

NOV1774449180

Novartis México

Cyber Attack

100

06/2022

NOV21267722

Loading…

A.I.

Novartis México Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Novartis México

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis México in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Novartis México in 2026.

Incident Types Novartis México vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis México in 2026.

Incident History - Novartis México (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Novartis México Subsidiaries

Novartis México

Pharmaceutical Manufacturing

Website: www.novartis.com/mx-es

Company Size: 607

NovartisPharmaceutical Manufacturing

Novartis IndiaPharmaceutical Manufacturing

Novartis SciencePharmaceutical Manufacturing

Novartis Gene TherapiesBiotechnology Research

Novartis SlovakiaPharmaceutical Manufacturing

Novartis SingaporePharmaceutical Manufacturing

Novartis EspañaPharmaceutical Manufacturing

Novartis DanmarkPharmaceutical Manufacturing

Novartis SverigePharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis FinlandPharmaceutical Manufacturing

Novartis, Australia & New ZealandPharmaceutical Manufacturing

Novartis MagyarországPharmaceutical Manufacturing

Novartis SerbiaPharmaceutical Manufacturing

Novartis IsraelPharmaceutical Manufacturing

Novartis Hong KongPharmaceutical Manufacturing

Novartis MedicalPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis ItaliaPharmaceutical Manufacturing

Novartis RomâniaPharmaceutical Manufacturing

Novartis NederlandPharmaceutical Manufacturing

Novartis Nederland - NeurologieGeneesmiddelenproductie

Novartis Nederland - OncologieGeneesmiddelenproductie

Novartis Nederland - ReumatologieGeneesmiddelenproductie

Novartis Nederland - HematologieGeneesmiddelenproductie

Novartis Nederland - DermatologieGeneesmiddelenproductie

Novartis Nederland - Cardiovascular, Renal & Metabolism Geneesmiddelenproductie

Novartis NorgePharmaceutical Manufacturing

Novartis BrasilPharmaceutical Manufacturing

Novartis USPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis DeutschlandPharmaceutical Manufacturing

Novartis ColombiaPharmaceutical Manufacturing

Novartis CanadaPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis in SloveniaPharmaceutical Manufacturing

Novartis Gulf | نوفارتس الخليجPharmaceutical Manufacturing

Novartis ArgentinaPharmaceutical Manufacturing

Novartis Ireland Pharmaceutical Manufacturing

Novartis US MedicalPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis BeluxPharmaceutical Manufacturing

Novartis PortugalPharmaceutical Manufacturing

Loading…

Novartis México Similar Companies

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Loading…

NEWS

Novartis México CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 25, 2026 08:00 AM

Novartis Renews WHO Commitment to Treat Leprosy by 2030

Novartis renewed its commitment with the WHO to treat 1 million more leprosy patients by 2030, extending a long-running global health...

Read Article

August 13, 2025 07:00 AM

Dräger’s Atlan A350 Series Gains US DoD Security Certification

Dräger's Atlan A350 anesthesia workstation series earns US DoD cybersecurity certification, securing patient data in operating rooms.

Read Article

February 22, 2021 08:00 AM

Treatment Access: Priority in Mexico

The Access to Medicine Foundation reveals that Mexico is among the countries with more strategies for therapies access.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-9693

SUMMARY

Mattermost versions 10.11.x <= 10.11.20, 11.7.x <= 11.7.5 Mattermost fails to remove thread membership records when a user is removed from or leaves a team, which allows a previously removed user who is later re-invited to the team to view private channel thread root post content and metadata via the team threads API.. Mattermost Advisory ID: MMSA-2026-00682

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: 3.5)

cvss3

Base Score: 3.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.1

REFERENCES

https://mattermost.com/security-updates

CVE-2026-75587

SUMMARY

Mattermost Desktop App versions <=6.2 6.2.2.0 fail to redact the pre-auth secret when generating a diagnostics report, which allows a local attacker with access to a user's diagnostics report or log files to obtain the plaintext pre-auth secret configured for a connected server via inspecting the Server Connectivity (Step-3) diagnostics output. Mattermost Advisory ID: MMSA-2026-00716

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: 3.6)

cvss3

Base Score: 3.6

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:C/C:L/I:N/A:N

Impact Score

1.4

Exploitability

1.8

REFERENCES

https://mattermost.com/security-updates

CVE-2026-75078

SUMMARY

A security flaw has been discovered in SourceCodester Class and Exam Timetabling System 1.0. This affects an unknown part of the file /BSHRM1.php. Performing a manipulation of the argument course results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-67961

SUMMARY

An issue in O2OA v.10.0.2 allows a local attacker to execute arbitrary code via the the sandbox mechanism of the Invoke script execution.

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-67919

SUMMARY

An issue in Halo 2.25.4 allows a remote attacker to execute arbitrary code via the PluginEndpoint.java, installFromUri method, and DefaultPluginApplicationContextFactory components

Published

Date2026-08-17

Updated

Date2026-08-17

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…